There is no specific “research funding” program dedicated to Silagra 50 mg itself. Here’s the correct way to understand it: 1. Who actually funds “Silagra” research? Sildenafil (Silagra 50 mg) is a generic drug, not a patented new medicine. So research related to it is usually funded by: Pharmaceutical companies (manufacturers) Companies like Cipla and other generic drug makers fund: Bioequivalence studies (to prove it works like Viagra) Formulation development Manufacturing quality research Regulatory requirement-driven studies Studies required by agencies like the US FDA, CDSCO (India), EMA (Europe) These are not “curiosity research,” but approval/quality compliance studies Clinical research institutions / CROs Contract research organizations run trials funded by pharma companies Example: bioequivalence and safety studies in volunteers Independent academic research Universities may study sildenafil for: Blood flow physiology Pulmonary hypertension Drug delivery methods 2. Who does NOT fund it No single “Silagra research foundation” No government funds it as a unique molecule (it’s already generic and well-established) No ongoing large innovation trials (like new drugs) 3. Simple summary Silagra research is mainly funded by: generic drug manufacturers + regulatory approval requirements Not by a special scientific program or a single sponsor.